News UK teams up with Singapore on healthtech regulation A partnership between medicines regulators in the UK and Singapore could allow patients in both countries to access new medical advances more quickly.
News AI health tech Respiree closes $11.6m Series A Health tech Respiree, developer of AI platforms to manage disease progression, has announced the successful closing of an $11.6m Series A financing.
News Sanofi opens $595m manufacturing facility in Singapore Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid switching between products
News AstraZeneca unveils plan for $1.5bn ADC plant in Singapore AstraZeneca is backing up its considerable investment in antibody-drug conjugates (ADCs) for cancer with the construction of a $1.5 billion new facility in Singapore to ma
News AbbVie invests $223m in Singapore biologics site AbbVie has broken ground on a new $223 million expansion of its biologics manufacturing facility in Singapore, creating around 100 new jobs.
News Novo Holdings co-leads $200m financing into Esco Lifescience... Life sciences tools company Esco Lifesciences Group has scored $200m in a series A and crossover round co-led by Novo Holdings and
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.